Sandbox:chf: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
|Increased [[Brain natriuretic peptide|BNP]] | |Increased [[Brain natriuretic peptide|BNP]] | ||
|[[Echocardiography]] (reduced EF) | |[[Echocardiography]] (reduced EF) | ||
|[[Diuretics]], [[ACE inhibitor|ACE inhibitors]], [[Angiotensin II receptor antagonist| | |[[Diuretics]], [[ACE inhibitor|ACE inhibitors]], [[Angiotensin II receptor antagonist|ARBs]], [[beta blockers]], [[nitrates]] | ||
|- | |- | ||
|Pericardial disease | |Pericardial disease | ||
Revision as of 20:10, 15 November 2016
chf
| Disease | Symptoms | Signs | Laboratory findings | Diagnostic modality | Management | |
|---|---|---|---|---|---|---|
| Cardiac | HFpEF | Exertional dyspnea, reduced exercise tolerance, orthopnea, paroxysmal nocturnal dyspnea, edema | Elevated JVP, fine crackles, edema | Increased BNP | Echocardiography (normal EF) | Control of volume overload and hypertension,
treatment of underlying condition (obesity, AF, coronary artery disease, anemia) |
| HFrEF | Exertional dyspnea, reduced exercise tolerance, orthopnea, paroxysmal nocturnal dyspnea, edema | Elevated JVP, fine crackles, edema | Increased BNP | Echocardiography (reduced EF) | Diuretics, ACE inhibitors, ARBs, beta blockers, nitrates | |
| Pericardial disease | ||||||
| Hypertrophic cardiomyopathy | ||||||
| Valvular disease | ||||||
| Arrhythmia | ||||||
| Pulmonary | Chronic airway disease | |||||
| Interstitial lung diseaee | ||||||
| Chronic thromboembolic disease | ||||||
| Sleep apnea | ||||||
| High output status | Anemia | |||||
| Thyrotoxicosis | ||||||
| Others | Liver disease | |||||
| Chronic kidney disease |